Infectious diseases in developing countries cost billions of dollars a year through livestock mortality and illness. Many Africa-specific diseases are neglected as there is little private investment in developing vaccines for them.
Vaccines are the most effective tool for infectious disease control. We aim to have vaccine candidates for some key diseases and two diagnostic assays ready for commercial production by 2022 with the potential to benefit millions of people through increased milk and meat yields.
Our comparative advantage is in the discovery to proof-of-concept phase. We develop generic vaccine-related platforms focused on our disease portfolio, but the technologies can be rapidly applied to other diseases. We work on key livestock diseases: African swine fever, contagious bovine pleuropneumonia, contagious caprine pleuropneumonia, East Coast fever and peste des petits ruminants.